Prior Auth Required
44103 - 7 Zevaskyn prescribing information, Abeona Therapeutics Inc., Cleveland, OH . 8/2025 8/2025
This procedure appears on the selected insurer prior authorization source.
Prior authorizationPrior Auth Required
Procedure / Service7 Zevaskyn prescribing information, Abeona Therapeutics Inc., Cleveland, OH . 8/2025 8/2025
Procedure / Service Description
Beremagene Geperpavec (B-VEC), an investigational, topical gene therapy, for the treatment of - with%20EB. 6 Vyjuvek prescribing information, Krystal Biotech, Inc., Pittsburgh, PA 15203 5/2023 3/2025 7 Zevaskyn prescribing information, Abeona Therapeutics Inc., Cleveland, OH 44103. 8/2025 8/2025 Filsuvez prescribing information. Pharmazeutische Fabrik. Germany 5/2024 1/2026 CAPITAL DISTRICT PHYSICIANS’ HEALTH PLAN, INC.
Likely documents
- Confirm benefit details
- Submit clinical notes if requested by the plan
Next actions
- Confirm the current plan policy before submission.
- Use the insurer authorization workflow for this listed code.